Amedisys (AMED) PT Raised to $133 at RBC Capital
Tweet
Share
E-mail
Get Alerts AMED Hot Sheet
Price: $100.99 --0%
Rating Summary:
6 Buy, 15 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 20
Rating Summary:
6 Buy, 15 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 20
Join SI Premium – FREE
RBC Capital analyst Frank Morgan raised the price target on Amedisys (NASDAQ: AMED) to $133.00 (from $126.00) while maintaining a Outperform rating following solid Q4.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Freedom Broker Upgrades PrimeEnergy Resource (PNRG) to Hold
- Central Retail Corp PCL (CRC:TB) PT Lowered to THB9,000 at Macquarie
- JD Logistics Inc (2618:HK) (JDLGF) PT Lowered to HK$18 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
RBC CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
